Thermo Fisher, NSG BIO collaborate to empower biotech startups in Singapore
This partnership enables Thermo Fisher and NSG BIO to support research efficiency, accelerate innovation, and advance local healthcare and life sciences capabilities.
SINGAPORE – Thermo Fisher Scientific Inc., the world leader in serving science, and NSG BioLabs recently signed a strategic Memorandum of Understanding to empower biotech startups in Singapore.
NSG BioLabs is Singapore’s largest co-working Biosafety Level 2 (BSL-2) laboratory. It has four fully equipped labs, office spaces, and 400+ pieces of equipment designed to launch revolutionary biotechnology ventures.
They leverage Singapore’s research capabilities and dynamic academic and startup ecosystem to transform groundbreaking ideas into world-changing biotech breakthroughs.
Since 2019, NSG BIO has supported innovators in creating impactful solutions across the health, biomedical, agrifood, and industrial biotechnology sectors, with work ranging from precision medicine to AI-enabled drug discovery and synthetic biology.
This partnership enables Thermo Fisher and NSG BIO to support research efficiency, accelerate innovation, and advance local healthcare and life sciences capabilities, aligning with national efforts to strengthen the sectors.
“We are excited to collaborate with NSG BIO to support Singapore’s growing biotech ecosystem,” said Ms. Sho-Wen Yeo, Vice President and General Manager, Southeast Asia & Taiwan, Thermo Fisher Scientific.
Thermo Fisher delivers a combination of innovative technologies, purchasing convenience, and pharmaceutical services globally through its brands: Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
“By ensuring seamless access to cutting-edge instruments and essential consumables, we enable scientists to focus on their critical research without operational challenges. This collaboration underscores our commitment to advancing scientific innovation and supporting the biotech community in Singapore,” Ms. Sho-Wen Yeo added.
By providing access to high-quality infrastructure, its extensive partner network, community, and value-add benefits, NSG BIO ensures that companies, ranging from emerging biotech startups to multinational companies, can rapidly and efficiently execute on their cutting-edge research and development ecosystem in Singapore.
“This strategic collaboration with Thermo Fisher Scientific marks a major milestone in our mission to drive biotech innovation in Singapore,” said Ms. Daphne Teo, Founder and Chairwoman of NSG BIO.
“By providing our residents with preferential access to world-class laboratory equipment and supplies, along with flexible credit terms, we are eliminating critical barriers that often hinder early-stage research. This collaboration reinforces our commitment to building a thriving biotech ecosystem where startups can accelerate breakthrough discoveries.”
Thermofischer joins eleven other NSG BioLabs partners, reinforcing NSG Bio’s position at the forefront of Singapore’s biotech ecosystem.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
